Navigation Links
Hypogonadism in Medical News

Men with Low Testosterone See Multiple Doctors Before Being Diagnosed; Many Dissatisfied with Current Treatment Options

... Although testosterone levels decline with age, hypogonadism is not a natural consequence of the aging process. "Men with clinically diagnosed hypogonadism do not need to 'tolerate' the symptoms of low ... by Bayer Schering Pharma AG. ABOUT hypogonadism Hypogonadism, also known as low ...

Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show

... new long-term clinical trial data in men with hypogonadism who were treated for 21 months with testosterone ... at Harvard Medical School . "But treating hypogonadism can result in significant health benefits for ... Morgentaler noted: "Because men who suffer from hypogonadism need to remain on treatment for life, it is very ...

New recommendations by scientific societies about late-onset hypogonadism

... published by Elsevier, will feature new recommendations on late-onset hypogonadism (LOH), recently formulated by major scientific organizations. LOH is a ... symptoms and a deficiency in serum testosterone levels. Late-onset hypogonadism (LOH) is caused by a decline in gonadal production of androgens in males ...

FDA Accepts New Drug Application for NEBIDO(R) Submitted by Indevus

... to NEBIDO from Bayer Schering Pharma AG, Germany in July 2005. About hypogonadism Male hypogonadism is an increasingly recognized medical condition characterized by a reduced ...

QuatRx Announces Further Positive Phase 3 Results For Ophena(TM) (Ospemifene Tablets) in Postmenopausal Vaginal Atrophy

... program. Fispemifene is a new selective estrogen receptor antagonist that is in Phase 2 studies as an oral treatment for the symptoms of secondary hypogonadism in men. Sobetirome, a novel, selective thyroid receptor beta agonist, is in Phase 1 as a potential treatment for dyslipidemia. Becocalcidiol, a novel ...

Pharmacyclics Announces Dr. Ahmed Hamdy as New Chief Medical Officer

... 2004, Dr. Hamdy was a Senior Principal Scientist at Watson Pharmaceuticals where he participated in an ANDA for testosterone gel for the treatment of hypogonadism that was approved 2005. He also participated in multiple INDs in oncology and autoimmune diseases leading to successful phase I and phase II ...

Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals

... markets products to treat overactive bladder, prostate cancer and central precocious puberty and is pursuing regulatory approval of drugs to treat hypogonadism and bladder cancer. Mr. Holveck noted, "In addition to the very successful drug, VANTAS(R), we are particularly excited about the opportunity to ...

JCI online early table of contents: July 1, 2008

... and colleagues, at Massachusetts General Hospital, Boston, has identified mutations in the FGF8 gene in individuals with idiopathic hypogonadotropic hypogonadism (IHH), a disease characterized by failed sexual maturation and infertility due to a deficiency in the small protein gonadotropin-releasing hormone ...

Low Serum Testosterone Levels Associated With Fall Risk in Elderly Men

... Prolonged hypogonadism may result in erectile dysfunction, decreased libido, anemia, sarcopenia, ... level is well-known for its association with osteoporosis, the impact of hypogonadism on overall physical functioning and fall risk has not been prospectively ...
Hypogonadism in Medical Technology

FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)

... in Europe and other territories. About hypogonadism Male hypogonadism is an increasingly recognized medical condition ... impair quality of life. Common effects of hypogonadism include decreased sexual desire, erectile ...

Indevus Announces Submission of New Drug Application

... reported were comparable to other injectable hypogonadism treatments reported in the literature. There were ... Schering Pharma AG, Germany in July 2005. About hypogonadism Male hypogonadism is an increasingly recognized medical ...

Novel Testosterone Gel Significantly Improves Insulin Sensitivity and Sexual Function in Hypogonadal Men With Type 2 Diabetes and Metabolic Syndrome

... 40-69 years, it is estimated that there are about 481,000 new cases of hypogonadism per year. Overall, approximately 2.4 million U.S. men suffer from the condition.(1) hypogonadism results from a deficiency in testosterone secretion that may occur ...

Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association

... previously announced, are based on a Phase III study in which men with hypogonadism and low serum testosterone levels prior to entering the study were treated ... Schering Pharma AG, Germany in July 2005. About Hypogonadism Male hypogonadism is an increasingly recognized medical condition characterized by a reduced ...

QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy

... program. Fispemifene is a new selective estrogen receptor antagonist that is in Phase 2 as an oral treatment for the symptoms of secondary hypogonadism and other conditions in men. Sobetirome, a novel, selective thyroid receptor beta agonist, is in Phase 1 as a potential treatment for dyslipidemia. ...

QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy

... program. Fispemifene is a new selective estrogen receptor antagonist that is in Phase 2 studies as an oral treatment for the symptoms of secondary hypogonadism in men. Sobetirome, a novel, selective thyroid receptor beta agonist, is in Phase 1 studies as a potential treatment for dyslipidemia. Asord(TM) ...

QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome

... program. Fispemifene is a new selective estrogen receptor antagonist that is in Phase 2 studies as an oral treatment for the symptoms of secondary hypogonadism in men. Sobetirome, a novel, selective thyroid receptor beta agonist, is in Phase 1 as a potential treatment for dyslipidemia. Becocalcidiol, a novel ...

Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy

... program. Fispemifene is a new selective estrogen receptor antagonist that is in Phase 2 studies as an oral treatment for the symptoms of secondary hypogonadism in men. Sobetirome, a novel, selective thyroid receptor beta agonist, is in Phase 1 studies as a potential treatment for dyslipidemia. Asord(TM) ...

Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture

... endocrinologists, orthopedists and select primary care physicians. Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 190-person sales and marketing team. Auxilium has four projects in clinical development. XIAFLEX(TM) (clostridial ...

QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy

... program. Fispemifene is a new selective estrogen receptor antagonist that is in Phase 2 studies as an oral treatment for the symptoms of secondary hypogonadism in men. Sobetirome, a novel, selective thyroid receptor beta agonist, is in Phase 1 studies as a potential treatment for dyslipidemia. Asord(TM) ...

More>>

Hypogonadism in Medical Definition

Pathology

... Adrenal insufficiency ( Addison's disease ) - Hypoaldosteronism Gonads Polycystic ovary syndrome - 5-alpha-reductase deficiency - hypogonadism - Delayed puberty - Precocious puberty Other Autoimmune polyendocrine syndrome - Carcinoid syndrome - Laron syndrome - ...
Hypogonadism in Medical Dictionary

Hypogonadism

... Hypogonadotropic hypogonadism Alternative Names: Gonad otropin deficiency ; Kallmann syndrome ; Secondary hypogonadism Prevention : ... Male hypogonadism Types of testosterone therapy Several types of ...

Hypothalamic

... from secondary ( hypothalamic or pituitary) hypogonadism . Autonomic dysfunction may be associated with ... FSH levels may help determine if hypothalamic hypogonadism (low FSH ) or testicular factors (high FSH ) ... alcohol or heavy metals; (2) hypogonadotropic hypogonadism ( congenital or acquired)— idiopathic ...

Testes

... testes . This test is used to differentiate hypogonadism ( ovary or testes ) into primary hypogonadism (problem is with the ovary or testes ) or secondary hypogonadism (problem is with the pituitary gland or the ...

Aplastic anemia

... Glaucoma ( Glaucoma ) Secondary Hyperparathyroidism Secondary hypogonadism (Hypogonadotropic hypogonadism ) ... Conditions that can decrease WBC values include chemotherapy , ...

Cryptorchidism

... a deficiency or absence of endogenous testosterone : (1) primary hypogonadism ( congenital or acquired)—testicular failure due to ... ECG . Affected people may have abnormal genitalia ( cryptorchidism ), hypogonadism , or delayed puberty . ^ Top ... At birth , it remains up in the ...

Testosterone

... abnormally low testosterone levels - a medical condition called male hypogonadism . Testosterone should not be used if you are taking the supplement ... SEPA/ testosterone gel In clinical trials for the treatment of male hypogonadism . Combining testosterone gel with the SEPA absorption enhancer allows ...

Anorexia

... fractures and can develop osteoporosis at a younger age than women without eating disorders . anorexia nervosa primary and secondary hypogonadism turner's syndrome , seen in females with one missing X chromosome ... anorexia nervosa An eating disorder manifested primarily by a loss ...

Anorexia Nervosa

... fractures and can develop osteoporosis at a younger age than women without eating disorders . anorexia nervosa primary and secondary hypogonadism turner's syndrome , seen in females with one missing X chromosome ... anorexia nervosa An eating disorder manifested primarily by a loss ...

Atherosclerosis

... of ED cases. Between 35 and 50 percent of men with diabetes experience ED. Additional features in some cases include hypothyroidism , male hypogonadism , short stature and mild to moderate developmental delay and the complications of type 2 diabetes such as hyperlipidemia (high lipid s) and ...

Atrophy

... vasomotor symptoms associated with menopause , (2) treatment of vulva l and vagina l atrophy , (3) treatment of hypoestrogenism due to hypogonadism , castration , or primary ovarian failure, ... Possible side effects associated with chronic and prolonged use of topical corticosteroids ...

More>>

Hypogonadism in Biological News

Study identifies pathway required for normal reproductive development

... of Medicine. The current study is the latest in a series of investigations by the MGH group into the genetic basis of idiopathic hypogonadotropic hypogonadism (IHH), a rare condition in which puberty does not take place naturally. IHH occurs when a structure in the brain called the hypothalamus fails to ...

New licensing agreement to maximize AIDS drug development

... and South Korea. FortigelTM (testosterone gel), branded Tostrex® outside the United States, is marketed in Sweden for the treatment of male hypogonadism also by ProStrakan. Approvals of Rectogesic and Tostrex by the other member states of the European Union are being sought through the Mutual ...
Hypogonadism in Biological Technology

QuatRx Pharmaceuticals to Present at 26th Annual JP Morgan Healthcare Conference

... programs. Fispemifene is a new selective estrogen receptor antagonist that is in Phase 2 studies as an oral treatment for the symptoms of secondary hypogonadism in men. QRX-431, a novel, selective thyroid receptor beta agonist, is in Phase 1 studies as a potential treatment for lipid disorders and obesity. ...
Hypogonadism in Biological Definition

Infertility

... i.e. diabetes mellitus , thyroid disorders Hypothalamic disorders, i.e. Kallmann syndrome Hyperprolactinemia Hypopituitarism hypogonadism due to various causes Psychological factors Drugs, alcohol Testicular factors Genetic causes, e.g. Klinefelter syndrome Neoplasm, ....
Other Contents
(Date:8/22/2014)... Renal artery stenting to open blockages in ... historically been excluded from modern clinical trials, according ... in Catheterization and Cardiovascular Interventions today ... (SCAI). , University Hospitals Case Medical Center,s Sahil ... Professor of Medicine, Case Western Reserve University School ...
(Date:8/22/2014)... August 22, 2014 Home Care ... in-home care for seniors, is proud to announce the ... The upcoming webinar will feature Dr. Suzanne Steinbaum, attending ... Hill Hospital in New York City, National Spokesperson for ... The webinar will cover the issues surrounding women and ...
(Date:8/22/2014)... Aug. 22, 2014 (HealthDay News) -- Many children get ... vaccination, but there are a number of ways that ... an expert suggests. The first step is to ... vaccinations help protect their health, said Rita John, director ... Columbia University School of Nursing in New York City. ...
(Date:8/22/2014)... few years, several breakthrough treatments have become available ... may benefit from these treatments can be pre-identified ... cancer. For example, patients whose lung cancer is ... significant benefit from the drug crizotinib, which targets ... attempting to replicate this success by matching different ...
(Date:8/22/2014)... who need surgery for facial pain caused by trigeminal ... used, reports a study in the September issue of ... Congress of Neurological Surgeons . The journal is ... part of Wolters Kluwer Health . , Percutaneous ... lower cost than other types of surgical treatments for ...
Breaking Medicine News(10 mins):Health News:UH Case Medical Center's Dr. Parikh authors SCAI paper on renal artery stenosis treatment 2Health News:UH Case Medical Center's Dr. Parikh authors SCAI paper on renal artery stenosis treatment 3Health News:Home Care Assistance of Centennial to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 2Health News:Home Care Assistance of Centennial to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 3Health News:Simple Steps Make Shots Less Scary for Kids, Nurse Says 2Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 2Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 3Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 4Health News:More common procedures for painful facial tics carry high costs, reports study in Neurosurgery 2
(Date:8/22/2014)... captive black rhino reproduction in Europe highlights how ... programmes. , Researchers from Chester Zoo, The University ... out a six-year study which encompassed 90% of ... Edwards led the research as part of her ... "Although some black rhinoceros breed well in captivity, ...
(Date:8/22/2014)... CAEveryone,s heard of the birds and the bees. ... that are being fertilized. The fertilization process for ... communication between the male and female reproductive cells. ... Regensburg, Heidelberg, and Munich, and including Carnegie,s Wolf ... in the chemical signaling process that guides flowering ...
(Date:8/21/2014)... , Aug. 21, 2014 Nxt-ID, Inc. ... growing mobile commerce market, announced today that its shares ... stock to be issued in its proposed underwritten public ... for listing on The Nasdaq Capital Market, subject to ... common stock and warrants, and will trade under the ...
Breaking Biology News(10 mins):Hormone analysis helps identify horny rhinos 2Calcium and reproduction go together 2Nxt-ID Approved for NASDAQ Capital Market Listing 2Nxt-ID Approved for NASDAQ Capital Market Listing 3
Other TagsOther Tags